HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Polynitroxyl albumin inhibits inflammation and vasoocclusion in transgenic sickle mice.

Abstract
Individuals with sickle-cell disease (SCD) and transgenic sickle mice expressing human betaS globin exhibit enhanced reactive oxygen species (ROS) production, vascular inflammation, and episodic vasoocclusion. We hypothesize that reduction of ROS will reduce endothelial-cell activation and adhesion-molecule expression, thereby inhibiting vasoocclusion. To test this hypothesis, we measured endothelial-cell activation, adhesion-molecule expression, and vasoocclusion in sickle mice after administering i.v. polynitroxyl albumin (PNA), a superoxide dismutase and catalase mimetic. Untreated sickle mice, compared with normal mice, showed increased activation of nuclear factor-kappaB (NF-kappaB), an oxidant-sensitive transcription factor, in their lungs, livers, and skin. NF-kappaB activation was increased further in the livers and skin of sickle but not normal mice after hypoxia-reoxygenation. IV administration of PNA inhibited NF-kappaB activation by 60% (P < .01) in the lungs and by 33% (P < .05) in the livers of sickle mice after hypoxia-reoxygenation. PNA also reduced the expression of vascular cell-adhesion molecule-1 (VCAM-1) by 57% in lung (P < .05) and by 33% in liver (P < .05) and reduced the expression of intercellular-adhesion molecule-1 (ICAM-1) by 40% in lung (P < .05) and by 53% in liver (P < .05). PNA inhibited a hypoxia-reoxygenation-induced increase in leukocyte rolling (P < .01) and adhesion (P < .05) in venules of the dorsal skin. Most importantly, PNA completely inhibited hypoxia-reoxygenation-induced vasoocclusion (P < .001). Control albumin had no effect on NF-kappaB, VCAM-1, ICAM-1, rolling, adhesion, or vasoocclusion. We speculate that therapies to reduce oxidative stress will inhibit inflammation and vasoocclusion in SCD.
AuthorsHemchandra Mahaseth, Gregory M Vercellotti, Thomas E Welch, Paul R Bowlin, Khalid M Sonbol, Carleton J C Hsia, Ma Li, John C Bischof, Robert P Hebbel, John D Belcher
JournalThe Journal of laboratory and clinical medicine (J Lab Clin Med) Vol. 145 Issue 4 Pg. 204-11 (Apr 2005) ISSN: 0022-2143 [Print] United States
PMID15962839 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Albumins
  • Antioxidants
  • Nitrogen Oxides
  • polynitroxyl-albumin
Topics
  • Albumins (pharmacology)
  • Anemia, Sickle Cell (complications, drug therapy, physiopathology)
  • Animals
  • Antioxidants (pharmacology)
  • Female
  • Inflammation (drug therapy, etiology, physiopathology)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Microcirculation (drug effects)
  • Nitrogen Oxides (pharmacology)
  • Oxidative Stress
  • Vascular Diseases (drug therapy, etiology, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: